[go: up one dir, main page]

DK1080070T3 - Antiangiogent lægemiddel til behandling af cancer, artritis og retinopati - Google Patents

Antiangiogent lægemiddel til behandling af cancer, artritis og retinopati

Info

Publication number
DK1080070T3
DK1080070T3 DK99924434T DK99924434T DK1080070T3 DK 1080070 T3 DK1080070 T3 DK 1080070T3 DK 99924434 T DK99924434 T DK 99924434T DK 99924434 T DK99924434 T DK 99924434T DK 1080070 T3 DK1080070 T3 DK 1080070T3
Authority
DK
Denmark
Prior art keywords
retinopathy
arthritis
cancer
treatment
antiangiogenic drug
Prior art date
Application number
DK99924434T
Other languages
English (en)
Inventor
Megumi Kawai
Jack Henkin
George S Sheppard
Richard A Craig
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1080070T3 publication Critical patent/DK1080070T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99924434T 1998-05-22 1999-05-21 Antiangiogent lægemiddel til behandling af cancer, artritis og retinopati DK1080070T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8406398A 1998-05-22 1998-05-22
PCT/US1999/011309 WO1999061406A2 (en) 1998-05-22 1999-05-21 Antiangiogenic drug to treat cancer, arthritis and retinopathy

Publications (1)

Publication Number Publication Date
DK1080070T3 true DK1080070T3 (da) 2007-02-26

Family

ID=22182661

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99924434T DK1080070T3 (da) 1998-05-22 1999-05-21 Antiangiogent lægemiddel til behandling af cancer, artritis og retinopati

Country Status (10)

Country Link
EP (1) EP1080070B1 (da)
JP (1) JP4554816B2 (da)
AT (1) ATE346036T1 (da)
CA (1) CA2332535C (da)
CY (1) CY1105977T1 (da)
DE (1) DE69934113T2 (da)
DK (1) DK1080070T3 (da)
ES (1) ES2276519T3 (da)
PT (1) PT1080070E (da)
WO (1) WO1999061406A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632961B1 (en) 1998-05-22 2003-10-14 Abbott Laboratories Antiangiogenic drug to treat cancer, arthritis and retinopathy
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
EP1463505A2 (en) * 2001-12-13 2004-10-06 Abbott Laboratories 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
ATE419242T1 (de) * 2003-10-09 2009-01-15 Abbott Lab Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
US7592466B2 (en) 2003-10-09 2009-09-22 Abbott Laboratories Ureas having antiangiogenic activity
US8039430B2 (en) * 2005-01-13 2011-10-18 University Of Wollongong Peptidic compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1922205A (en) * 1932-01-26 1933-08-15 Squibb & Sons Inc 2-carboxy-5-amino diphenyl
GB1498996A (en) * 1975-10-09 1978-01-25 Hidaka H Omega-aminoalkanoic acid arylamides
IT1050750B (it) * 1975-12-05 1981-03-20 Erba Carlo Spa Derivati della 3.4 di idro chinazolina
US4147802A (en) * 1978-03-17 1979-04-03 Stanley Drug Products, Inc. Method of treating bacterial infections
DE3577700D1 (de) * 1984-11-30 1990-06-21 Shosuke Okamoto Lysinderivat und proteinase-inhibitor.
US5238652A (en) * 1990-06-20 1993-08-24 Drug Screening Systems, Inc. Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques
GB9200415D0 (en) * 1992-01-09 1992-02-26 Bagshawe Kenneth D Inactivation of cytotoxic drugs
ZA935617B (en) * 1992-08-14 1994-03-07 Akzo Nv Antiprogestogen containing contraceptives.

Also Published As

Publication number Publication date
CY1105977T1 (el) 2011-04-06
JP4554816B2 (ja) 2010-09-29
EP1080070B1 (en) 2006-11-22
CA2332535A1 (en) 1999-12-02
CA2332535C (en) 2006-02-28
WO1999061406A3 (en) 2000-01-27
ES2276519T3 (es) 2007-06-16
ATE346036T1 (de) 2006-12-15
PT1080070E (pt) 2007-02-28
DE69934113D1 (de) 2007-01-04
DE69934113T2 (de) 2007-06-06
EP1080070A2 (en) 2001-03-07
JP2002516303A (ja) 2002-06-04
WO1999061406A2 (en) 1999-12-02

Similar Documents

Publication Publication Date Title
NO20003018L (no) Triazinangiogenese-inhibitorer
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
DE60045426D1 (de) Phenyl-benzyl-ketone
DE602004017479D1 (de) Als neue antiangiogene mittel geeignete thienopyridinphenylacetamide und derivate davon
CY1110361T1 (el) Φαρμακευτικες συνθεσεις ως αναστολεις διπεπτιδυλικης πεπτιδασης iv (dpp-iv)
ATE238981T1 (de) Antitumorwirkstoffe
DE60102171D1 (de) Ketolidantibiotika
ATE297904T1 (de) Halo-alkoxycarbonylverbindungen
MXPA04003611A (es) Piperidina- y piperazinacetaminas como inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes.
CY1105977T1 (el) Αντι-αγγειογονικο φαρμακο για να θepαπευεται καρκινος, αρθριτιδα και αμφιβληστροειδοπαθεια
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
ATE407923T1 (de) Tyrosinderivate als phosphatase inhibitoren
TW200730177A (en) 4 anilino-3-quinolinecarbonitriles for the treatment of cancer
DK1353660T3 (da) Anvendelse af substituerede 6-dimethylaminomethyl-1-phenylcyclohexanforbindelser til behandling af urininkontinens
DK1212315T3 (da) Nye chalconer
DK1077694T3 (da) Arylnitron-terapeutika til behandling af inflammatorisk tarmsygdom
ATE263556T1 (de) Phenylessigsäure enthaltende zusammensetzungen zur behandlung und vorbeugung der atherosklerose und der restenose
DK1551850T3 (da) 2"-oxo-voruscharin og derivater deraf
AR013802A1 (es) Inhibidores de angiogenesis de triazina
UA84544C2 (ru) Замещенные фенилсульфонамидные ингибиторы продукции бета-амилоида
PT1370526E (pt) Diamidas que inibem a actividade da triptase e do factor xa